VEGF 165, also known as Vascular Endothelial Growth Factor 165, is a protein that plays a critical role in angiogenesis, the process of forming new blood vessels from pre-existing ones. It belongs to the vascular endothelial growth factor family and is one of the most well-studied isoforms of VEGF. Human VEGF 165 protein is a crucial regulator of angiogenesis, with implications in various physiological and pathological processes. Its study contributes to our understanding of blood vessel development, tissue repair, and the development of therapeutic strategies for diseases such as cancer. Product Properties Synonyms MVCD1, VAS, vascular endothelial growth factor A, VEGF, VEGFA, VPF Uniprot No. P15692-4 Source HEK293 cells-derived human VEGF 165 protein, Ala27-Arg191, with C-terminal his tag. Molecular Weight The protein has a predicted MW of 20.25 kDa. And it migrates as 20-28 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. Purity > 90% as determined by SDS-PAGE. Endotoxin < 1 EU per μg of the protein by the LAL method. Formulation Lyophilized from a 0.2 μm filtered concentrated solution in PBS. Reconstitution Centrifuge tubes before opening. Dissolve lyophilized protein with PBS to ensure the concentration is greater than 100 ug/mL.Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles. Shipping and Storage The product should be stored at -25~-15℃ for 1 year from date of receipt. 2-7 days, 2 ~8 °C under sterile conditions after reconstitution. 3 months, -25~-15℃ under sterile conditions after reconstitution. Cautions 1.Please operate with lab coats and disposable gloves, for your safety. 2.This product is for research use only. Documents: Safety Data Sheet 91502_MSDS_HB250804.PDF Manuals 91502_Manual_Ver.EN20250804.pdf
